BIOFILCHEM (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Biofil Chemicals and Pharmaceuticals Limited |
|||
|
Price: ₹59.51 | ||
| 52 Week Low: ₹53.45 52 Week High: ₹91.87 |
|||
| Market Capital: 102.02 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: BIOFILCHEM Share Price Target For 2024
- 1.1.1: BIOFILCHEM Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: BIOFILCHEM Share Price Target For 2025
- 1.2.1: BIOFILCHEM Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: BIOFILCHEM Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: BIOFILCHEM Brief Company Overview
- 4: BIOFILCHEM Financial Performance
- 4.0.1: Is BIOFILCHEM A Good Buy For Long Term?
To predict the BIOFILCHEM's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
BIOFILCHEM Share Price Target For 2024
The line chart displays the monthly closing prices of BIOFILCHEM with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for BIOFILCHEM shares in 2024, see the table below.
BIOFILCHEM Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 62.3 (+4.68%) | Price Action: 06 Jun 2024 High |
| 2024 Target 2 | 61.65 (+3.59%) | Price Action: May 2024 Low |
| 2024 Target 1 | 61.03 (+2.54%) | Price Action: 20 Jun 2024 Low |
| Current Price | 59.51 | BIOFILCHEM's share price as of 26 Dec 2024 |
| Stop Loss 1 | 58.8 (-1.2%) | Price Action: 03 Jan 2024 High |
| Stop Loss 2 | 58.2 (-2.21%) | Price Action: 12 Jan 2024 Low |
| Stop Loss 3 | 57.6 (-3.21%) | Price Action: 23 Jan 2024 High |
Short-Term Technical Outlook
Current Technical Position: BIOFILCHEM is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹62.81 serves as the nearest technical reference point.
Historical Returns: 3-month: -27.38% | 6-month: -7.54% | 1-year: +9.9%
BIOFILCHEM Share Price Target For 2025
The line chart displays the monthly closing prices of BIOFILCHEM with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for BIOFILCHEM shares in 2025, see the table below.
BIOFILCHEM Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 87.8 (+47.53%) | Price Action: 18 Sep 2024 High |
| 2025 Target 2 | 85.9 (+44.34%) | Price Action: 20 Sep 2024 High |
| 2025 Target 1 | 84.2 (+41.48%) | Price Action: 24 Sep 2024 High |
| Current Price | 59.51 | BIOFILCHEM's share price as of 26 Dec 2024 |
| Stop Loss 1 | 53.4 (-10.27%) | Price Action: 11 Dec 2023 High |
| Stop Loss 2 | 52.6 (-11.62%) | Price Action: Feb 2023 High |
| Stop Loss 3 | 52.05 (-12.54%) | Price Action: 19 Dec 2023 Low |
Long-Term Technical Outlook
52-Week Range Analysis: BIOFILCHEM is currently trading near its 52-week low of ₹53.45, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: +9.9% | 3-year: -4.55% | 5-year: +188.88%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
BIOFILCHEM Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹59.51 | ||
| 2024 | ₹72.75 | +22.24% | ₹73.84 |
| 2025 | ₹101.34 | +39.29% | ₹102.86 |
| 2026 | ₹177.78 | +75.42% | ₹189.20 |
| 2027 | ₹247.76 | +39.36% | ₹251.48 |
| 2028 | ₹298.31 | +20.4% | ₹302.78 |
| 2029 | ₹231.68 | -22.33% | ₹306.32 |
| 2030 | ₹255.42 | +10.24% | ₹364.89 |
| 2031 | ₹385.06 | +50.75% | ₹423.45 |
| 2032 | ₹482.01 | +25.17% | ₹489.24 |
| 2033 | ₹535.49 | +11.09% | ₹543.52 |
| 2034 | ₹390.62 | -27.05% | ₹540.57 |
| 2035 | ₹409.51 | +4.83% | ₹599.13 |
| 2036 | ₹592.33 | +44.64% | ₹657.69 |
| 2037 | ₹716.25 | +20.92% | ₹726.99 |
| 2038 | ₹772.66 | +7.87% | ₹784.25 |
| 2039 | ₹539.65 | -30.15% | ₹774.81 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
BIOFILCHEM Brief Company Overview
Biofil Chemicals and Pharmaceuticals Limited: A Leading Pharmaceutical and Chemical Company Since its inception in 1985, Biofil Chemicals and Pharmaceuticals Limited has established itself as a prominent player in India's pharmaceutical and chemical sectors. Diverse...
Product Range: Biofil offers an extensive range of basic drugs and chemicals, including sodium chloride, ferrous sulfate, and dicyclomine hydrochloride. Plastic Products: The company also manufactures plastic dippers and caps for various industries. Job Work Services: Biofil provides job work services for the manufacturing of pharmaceuticals. Biofil Chemicals is dedicated to providing high-quality products and services while adhering to industry standards and ethical practices. Its strong commitment to innovation and customer satisfaction has earned it a stellar reputation within the industry.BIOFILCHEM Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 102.02 Crore | Market valuation of BIOFILCHEM's shares. |
| Revenue (TTM) | 46.04 Crore | Total revenue generated by BIOFILCHEM over the past twelve months. |
| Net Income (TTM) | +63.43 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +2.82% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +1.37% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+247% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-30.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
2.41 | Company's total debt divided by total shareholder equity. |
| Total Debt | 43.89 Lakh | Sum of BIOFILCHEM's current & long-term financial obligations. |
| Total Cash | 2.28 Crore | Total amount of liquid funds available to BIOFILCHEM. |
| Beta | 2.66 | Beta is greater than 1 indicating that the BIOFILCHEM's price is more volatile than the market. |
Is BIOFILCHEM A Good Buy For Long Term?
BIOFILCHEM, a small-cap stock with a market capitalization of ₹102.02 crore, presents a mixed picture for long-term investors. While its Q1 2024-25 cash balance of ₹2.28 crore and low debt of ₹43.89 lakh are positive, a meagre 1.37% profit margin on ₹46.04 crore revenue (TTM) and a significant decline in earnings (-30.7% YoY) raise concerns. Past performance shows volatility: a 25.95% return over the past 12 months contrasts sharply with a -66.04% return over the past three years. Overall, it's not a good buy for long-term investment at this time given the current financial performance. Further investigation is warranted.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
